Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk : A post hoc analysis of the first year of the frame study
Journal article
McCloskey, E. V., Johansson, H., Harvey, N. C., Lorentzon, K., Shi, Y. and Kanis, J. A.. (2021). Romosozumab efficacy on fracture outcomes is greater in patients at high baseline fracture risk : A post hoc analysis of the first year of the frame study. Osteoporosis International. https://doi.org/10.1007/s00198-020-05815-0
Authors | McCloskey, E. V., Johansson, H., Harvey, N. C., Lorentzon, K., Shi, Y. and Kanis, J. A. |
---|---|
Abstract | Summary Introduction Methods Results Conclusions |
Keywords | fracture reduction; fracture risk; FRAX; romosozumab |
Year | 2021 |
Journal | Osteoporosis International |
Publisher | Springer UK |
ISSN | 0937-941X |
Digital Object Identifier (DOI) | https://doi.org/10.1007/s00198-020-05815-0 |
Scopus EID | 2-s2.0-85100454619 |
Open access | Published as ‘gold’ (paid) open access |
Research or scholarly | Research |
Page range | 1-8 |
Publisher's version | License File Access Level Open |
Output status | In press |
Publication dates | |
Online | 03 Feb 2021 |
Publication process dates | |
Accepted | 30 Dec 2020 |
Deposited | 05 Aug 2021 |
https://acuresearchbank.acu.edu.au/item/8w754/romosozumab-efficacy-on-fracture-outcomes-is-greater-in-patients-at-high-baseline-fracture-risk-a-post-hoc-analysis-of-the-first-year-of-the-frame-study
Download files
Publisher's version
OA_McCloskey_2021_Romosozumab_efficacy_on_fracture_outcomes_is.pdf | |
License: CC BY-NC 4.0 | |
File access level: Open |
90
total views11
total downloads4
views this month1
downloads this month